Literature DB >> 19481265

Complement in human diseases: Lessons from complement deficiencies.

Marina Botto1, Michael Kirschfink, Paolo Macor, Matthew C Pickering, Reinhard Würzner, Francesco Tedesco.   

Abstract

Complement deficient cases reported in the second half of the last century have been of great help in defining the role of complement in host defence. Surveys of the deficient individuals have been instrumental in the recognition of the clinical consequences of the deficiencies. This review focuses on the analysis of the diseases associated with the deficiencies of the various components and regulators of the complement system and their therapeutic implications. The diagnostic approach leading to the identification of the deficiency is discussed here as a multistep process that starts with the screening assays and proceeds in specialized laboratories with the characterization of the defect at the molecular level. The organization of a registry of complement deficiencies is presented as a means to collect the cases identified in and outside Europe with the aim to promote joint projects on treatment and prevention of diseases associated with defective complement function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481265     DOI: 10.1016/j.molimm.2009.04.029

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  82 in total

1.  The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models.

Authors:  Masha Fridkis-Hareli; Michael Storek; Eran Or; Richard Altman; Suresh Katti; Fang Sun; Tao Peng; Jeff Hunter; Krista Johnson; Yi Wang; Ante S Lundberg; Gaurav Mehta; Nirmal K Banda; V Michael Holers
Journal:  Mol Immunol       Date:  2018-12-01       Impact factor: 4.407

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

3.  Henoch-Schönlein purpura with hypocomplementemia.

Authors:  Qiang Lin; Yue Min; Yanhong Li; Yun Zhu; Xiaoxiang Song; Qinying Xu; Lifeng Wang; Jiang Cheng; Qihua Feng; Xiaozhong Li
Journal:  Pediatr Nephrol       Date:  2012-01-21       Impact factor: 3.714

4.  Complement up-regulates Runx-2 to induce pro-fibrogenic change in aortic valve interstitial cells.

Authors:  Xin-Sheng Deng; Xianzhong Meng; David Fullerton; Matthew Stone; James Jaggers
Journal:  Ann Thorac Surg       Date:  2021-02-02       Impact factor: 4.330

Review 5.  Overview of the immune response.

Authors:  David D Chaplin
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 6.  The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.

Authors:  Joshua M Thurman; Ashley Frazer-Abel; V Michael Holers
Journal:  Arthritis Rheumatol       Date:  2017-10-17       Impact factor: 10.995

Review 7.  Clinical promise of next-generation complement therapeutics.

Authors:  Dimitrios C Mastellos; Daniel Ricklin; John D Lambris
Journal:  Nat Rev Drug Discov       Date:  2019-07-19       Impact factor: 84.694

8.  Hereditary Homozygous C3 Deficiency.

Authors:  Jigna N Bathia; Priyankar Pal; Mandira Roy; Souvik Guha
Journal:  Indian J Pediatr       Date:  2017-04-24       Impact factor: 1.967

Review 9.  Complement deficiencies in systemic lupus erythematosus.

Authors:  Angela R Bryan; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2014-07       Impact factor: 4.806

10.  Functional analysis of Ficolin-3 mediated complement activation.

Authors:  Estrid Hein; Christian Honoré; Mikkel-Ole Skjoedt; Lea Munthe-Fog; Tina Hummelshøj; Peter Garred
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.